Compare Nuwellis Inc (NUWE) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Oxford Lane Capital Corp — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Oxford Lane Capital Corp trades at $9.64 (market cap $942.56M). The key difference: Oxford Lane Capital Corp is far larger — about 377× Nuwellis Inc's market cap, and Oxford Lane Capital Corp pays a 24.96% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | OXLC | |
|---|---|---|
Market Cap | $2.50M | $942.56M |
Sector | Technology | Financials |
52-Week High | $164.50 | $17.73 |
52-Week Low | $0.73 | $8.15 |
Enterprise Value | -$1.21M | — |
Dividend Yield | — | 24.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
OXLC trades at $9.61, down 0.52% on the day, with a bullish technical signal supported by moving averages but mixed earnings performance. Recent quarters show significant misses versus expectations, including a large loss in Q1 2026, though the company maintains a steady dividend payout. Net income margin is exceptionally high at 100.85% for 2026, but this follows negative revenue, while 2025 showed positive net income of $48.46M. The P/B ratio of 0.91 suggests the stock trades below book value.
Outlook is cautious due to volatile earnings and high yield sustainability concerns, with analyst sentiment split evenly between buy and sell ratings. Key risks include earnings instability and reliance on financing cash flow, but the discount to book value and consistent dividends may appeal to income-focused investors amid bullish technical trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
